An Adaptive Reinforcement-Based Treatment (RBT) Intervention for Pregnant Substance Dependent Women
|
|
- Pauline Walsh
- 5 years ago
- Views:
Transcription
1 An Adaptive Reinforcement-Based Treatment (RBT) Intervention for Pregnant Substance Dependent Women Michelle Tuten, Ph.D. Assistant Professor Department of Psychiatry and Behavioral Sciences and Johns Hopkins University School of Medicine HIV Methods and Intervention Science Meeting September th 2013
2 National Institute on Drug Abuse R01DA14979 Participants Staff at the Center for Addiction and Pregnancy Hendree Jones (original study PI: slides adapted from 2011 CPDD workshop) Collaborators Susan Murphy, Pierre Alexander, Margaret Chisolm (current PI) Acknowledgements 2
3 Outline 1. Complexities of the Problem 2. Clinical Setting 3. Role of Behavioral Treatment 4. HOME II Study 3
4 National Survey on Drug Use and Health 2008/9 Past Month Use 1. Complexities of the Problem Alcohol and tobacco substances are the most commonly abused during pregnancy Minority but significant number of pregnant women (also use) illicit drugs during pregnancy Drug addiction begins before pregnancy and is the result of complex past and current factors 4
5 TREATMENT 1. Complexities of the problem Pregnancy is a window of opportunity for behavior change 5
6 1. Complexities of the problem Issues Facing Pregnant Drug Users Exposure to violence, trauma Generational drug use Lack of formal education Lack of work history or skills Legal involvement Multiple drug exposure Limited parenting skills History of abuse/neglect Psychiatric issues Unstable housing Lack of social support Medical issues Nutrition deficits 6
7 2. Clinical setting Center for Addiction and Pregnancy mission statement: Address Barriers to Care Improve maternal and infant outcomes Conduct clinical research 7
8 2. Clinical setting Comprehensive Care Interdisciplinary approach Substance abuse counseling Psychiatry Obstetrics Pediatrics Nursing Multiple modalities Medically-assisted withdrawal Methadone stabilization 8
9 2. Clinical setting Outcome research: cost effectiveness Clinical measure: CAP (n=100) No Treatment (n=46) Prenatal visits 8 4 EGA (mean week) % positive at delivery Infant birth weight (grams) Apgar scores (1 minute) 8 7 % NICU use Length of hospital stay (days) 7 39 Investing in CAP drug treatment services resulted in net savings of $4,644 in NICU costs. Although CAP is costeffective, many women continue to drop out of treatment prematurely and/or do not respond to treatment All group comparisons are significant: p.05 (Data adapted from Svikis et al., 1997) 9
10 3. Role of behavioral treatment Guiding Principles Drug addiction occurs in absence of alternative positive reinforcers Drug use makes sense in that it meets certain behavioral functions for the individual Drug use behavior can be modified using operant reinforcement Goal of treatment is for nondrug using behaviors become more reinforcing than drug use 10
11 Treatment Elements Recreational Activities Personalized Feedback Intensive Outreach Peer Support/ Social Club Patient 3. Role of behavioral treatment Behavior Graphing Vocational Assistance/ Job Club Functional Drug Use Assessment Treatment Elements Functional assessment (FA) Personalized feedback (MI adaptation) Social reinforcement (in the form of weekly Social Club) Behavior graphing Vocational assistance/job club Recreational activities Intensive outreach Tangible reinforcers 11
12 Treatment Elements 3. Role of behavioral treatment Treatment Objectives Functional Assessment (FA) of drug use Behavior Graphing Treatment attendance Recreational Activities Vocational Activities Medication compliance FA: when, where and why of drug use Constellation of behaviors that compete with drug use Graph these target behaviors 12
13 Abstinence (yes/no) Example of Close Behavioral Observation: DRUG FREE DAYS Good Job! Good Job! Role of Behavioral Treatment 15 Allow for connections between behaviors (if you do this, drug use occurs, if you do this, drug abstinence occurs) Larger goals are broken into smaller goals Positive reinforcement given for successes Days 13
14 Number of Applications Example Of Behavior Tracking 3. Role of Behavioral Treatment Number of Job Applications Goal= 9 applications/week week 1 week 2 week 3 week 4 Employment obtained 14
15 Days Drug Free Examples: Participant Treatment Progress 3. Role of Behavioral Treatment 15
16 Mean Days % Positive Urine Samples 3. Role of Behavioral Treatment Opioid and Cocaine Negative * RBT Control RBT (n=72) Control (n=128) * * * * 1-month 3-month 1-month 3-month Opioids Cocaine 3 randomized trials showing RBT s efficacy in nonpregnant patients (1 month, 6 months, 12 months follow-up) 1RBT adaptation and test in pregnant patients Opioid and Cocaine Negative * RBT Control RBT Delivery UC * As with any intervention, not all RBT-treated participants attended treatment or reduced drug use, suggesting room to improve patient response 16 (Gruber et al., 2000; Jones et al., 2005; Jones 2011; Tuten et al., 2012 * All treatment condition comparisons are significant at p.05 16
17 3. Role of Behavioral Treatment We identified two important questions regarding RBT for pregnant women: Would variants of RBT in terms of their intensity and scope be effective? Would patients who differed in terms of their treatment compliance be differentially responsive to these variants of RBT?
18 4. A SMART trial at HOME HOME II Eligibility Criteria Inclusion Criteria: Evidence of cocaine and/or opiate use Treatment entry at or before 32 weeks EGA with singleton fetus Completion of the eight-day residential detoxification stay Exclusion Criteria: Age 17 or younger Geographical Constraints Severe medical or psychiatric concomitant condition interfering with treatment or needing hospitalization 18
19 4. A SMART trial at HOME Primary Outcomes- Maternal: Treatment Completion (Delivery) Heroin Use Cocaine Use Secondary Outcomes- Neonatal : Birth weight Head Circumference Length of Hospital/NICU Stay Urine Toxicology at Delivery Physical Birth Parameters Neonatal Complications 19
20 Decisions for Designing the Trial: How to choose a design structure to answer questions of interest: Initial randomization conditions? Second randomization to what? Which treatment response characteristics: Was strongly related to outcome? Would allow reasonable tailoring? 4. A SMART trial at HOME Solutions: Initial Randomization: Compare TAU RBT to a potentially more cost effective form of RBT intervention Treatment Compliance as the tailoring variable: Failure to comply with treatment soon after treatment entry the biggest reason for failure to complete treatment Length of time to allow for assessment of the tailoring variable Pregnancy time-limited window Assess compliance during the first two weeks following treatment entry 20
21 Planned Sample Size 4. A SMART trial at HOME HOME II intervention adjusts in intensity or scope following patients initial treatment compliance or non-compliance. It is expected that RBT in an adaptive intervention format will optimize maternal treatment outcomes for both early compliant and early noncompliant participants by matching treatment to patient needs. 21
22 4. A SMART trial at HOME All non-methadone CAP Patients trbt: Treatment-as-usual RBT All elements of treatment-as-usual RBT trbt 5X/week: Individual sessions 3X/week: Recreation 3X/week: Job Club Random Assignment rrbt 3X/week: Individual sessions 1X/week: Recreation 1X/week: Job Club rrbt: reduced RBT Key RBT elements are provided at a reduced scope to examine a version of RBT that might be more in line with community practice limitations 22
23 4. A SMART trial at HOME Tailored Treatment Randomization Two-week window for treatment response Early compliant participants randomized to either the same intensity of treatment or a decreased intensity or scope of RBT treatment Early treatment non-compliance: (a) a missed unexcused treatment day, (b) a positive opioid or cocaine urine specimen, (c) or self-report of use of either drug. Early non-compliant participants randomized to receive either the same treatment or a greater intensity or scope of RBT 23
24 4. A SMART trial at HOME Increased intensity erbt: Enhanced RBT All trbt elements, plus: Home visits to re-engage participant/deliver therapy Immediate re-admission to the residential unit or community recovery housing as time out from drug use Decreased intensity arbt: Abbreviated RBT Most reduced version of RBT: Graphing drug abstinence Outreach limited to follow-up call Individual sessions once a week Recreation and social club once a month 24
25 4. A SMART trial at HOME Primary Aim: Relative efficacy of providing continued treatment-as-usual RBT in comparison to continued reduced RBT to both early-compilers and early noncompliers throughout the trial. Addresses the question of whether it is necessary to provide treatment-asusual RBT, or if it is possible to successfully treat patients with reduced RBT, regardless of the patient s level of compliance. 25
26 26 4. A SMART trial at HOME Secondary Aims: Early non-compliers: Relative efficacy of transitioning to a more intensive level of treatment for the TAU RBT and the reduced RBT conditions. Answers questions regarding the relative importance of the initial level of care in determining the efficacy of transitioning to a higher level of care for early-non compliers.
27 27 4. A SMART trial at HOME Secondary Aims (cont.): Early-compliers: relative efficacy of transitioning to a less intense level of treatment for within the initial TAU RBT and reduced RBT treatment conditions. Answers questions about the importance of the initial level of RBT treatment in determining success in subsequently reducing the level of RBT treatment in early-compliers.
28 4. A SMART trial at HOME Secondary Aims (cont.): Relative efficacy for early-complier and early-non-compliers who begin and continue in treatment-as-usual RBT or who begin and continue in reduced RBT, respectively. Answers the question about the relative decrement in treatment success that occurs as a result of an early failure to comply with the initial demands of treatment. 28
29 Current Enrollment 4. A SMART trial at HOME All non-methadone CAP Patients N= 230 trbt n =114 Random Assignment Tailoring Variable Randomization: Treatment Compliance rrbt n =116 Decrease Intensity Early Compliant n=48 Early Non- Compliant n=61 Increase Scope Increase Intensity Early Non- Compliant n=53 Early Compliant n=56 Decrease Scope rrbt n=24 trbt n=24 trbt n=30 erbt n=31 trbt n=26 rrbt n=27 rrbt n=28 arbt n=28
30 4. A SMART trial at HOME Challenges in Conducting the Trial Recruitment Participant adherence to assessment protocol Maintenance of distinct treatment conditions Adherence of the clinical staff to the protocol Changing clinical programming New Insights Resulting from the Trial Patient acceptance of the tailoring treatment randomization Better-than-expected distribution of patients into tailoring treatment randomization 30
31 4. A SMART trial at HOME: SUMMARY What we ve learned from process: Feasible and desirable Well-defined tailoring/response definitions Distinct and theoretically sound conditions Procedures to maintain conditions (and documented deviations) 31
On Adaptive Interventions and SMART
On Adaptive Interventions and SMART Daniel Almirall; Inbal (Billie) Nahum- Shani; Shawna Smith School of Nursing University of Michigan February 3, 2016 1 Outline Adaptive Intervention (AIs) What are AIs?
More informationMaternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC
Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC Objectives 1. Discuss the effects of opiate addiction on mothers and infants. 2. Discuss a Medical Home
More informationJohann Hari. Truths 2/29/2016. From the street to the NICU. Treatment works
From the street to the NICU Richard Christensen, PA, CAS Johann Hari Treatment works Truths Disconnect with pregnant women seeking treatment Disconnect between community and science Medication is not a
More information40 min. SMART Study Designs for Developing Adaptive Interventions. SA Murphy 1
40 min. SMART Study Designs for Developing Adaptive Interventions SA Murphy 1 Other names are dynamic treatment regimes, treatment algorithms, stepped care models, expert systems, adaptive treatment strategy,
More informationAnesthetics, Local a / or Anesthesia, Epidural a / or Anesthesia, Obstetrical a / or Pain, Postoperative a / or Postpartum Period a
Appendix 1. Literature Search Databases Years Search Terms Pubmed 01/1966 1. Analgesics, Opioid a / or Opioid-related Disorders a / PsycINFO EMBASE Cochrane 09/2016 or Heroin a / or Heroin Dependence a
More informationThe Opioid-Exposed Woman
The Opioid-Exposed Woman Management Considerations for Labor and Delivery Jane Sublette, MS, RN, CNM, WHNP-BC Fairview Ridges Hospital Objectives Describe opioid-associated risks to the mother and fetus
More informationFY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine
FY17 SCOPE OF WORK TEMPLATE Name of Program/Services: Medication-Assisted Treatment: Buprenorphine Procedure Code: Modification of 99212, 99213 and 99214: 99212 22 99213 22 99214 22 Definitions: Buprenorphine
More informationPrepublication Requirements
Issued Prepublication Requirements The Joint Commission has approved the following revisions for prepublication. While revised requirements are published in the semiannual updates to the print manuals
More informationNational Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says
National Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says Last Updated February 2016 https://www.drugabuse.gov 1 Table of Contents Understanding Drug Abuse and Addiction:
More informationGetting SMART about Adapting Interventions. S.A. Murphy Early Childhood Interventions Inaugural Conference 04/21/12
Getting SMART about Adapting Interventions S.A. Murphy Early Childhood Interventions Inaugural Conference 04/21/12 Adaptive Interventions are individually tailored sequences of interventions, with treatment
More information60 minutes Give examples of SMARTs that are completed or in the field o ASD, child ADHD, women who are pregnant and abuse substances, adult alcohol
60 minutes Give examples of SMARTs that are completed or in the field o ASD, child ADHD, women who are pregnant and abuse substances, adult alcohol use, depression Discuss the variety of rationales underlying
More informationDoing Time or Doing Treatment: Moving Beyond Program Phases to Real Lasting Change
Doing Time or Doing Treatment: Moving Beyond Program Phases to Real Lasting Change BJA Drug Court Technical Assistance Project at American University March 14, 2016 David Mee-Lee, M.D. Chief Editor, The
More informationADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines
The Clinical Level of Care Guidelines contained on the following pages have been developed as a guide to assist care managers, physicians and providers in making medical necessity decisions about the least
More informationMedication for the Treatment of Addiction (MAT)
Medication for the Treatment of Addiction (MAT) Karol Kaltenbach, PhD Emeritus Professor of Pediatrics Sidney Kimmel Medical College at Thomas Jefferson University Terminology: Words Matter Medication
More informationMedication-Assisted Treatment & Pregnancy. Dave Kneessy, MS, MAC, CAP, LMHC Regional Director Central Florida Treatment Centers
Medication-Assisted Treatment & Pregnancy Dave Kneessy, MS, MAC, CAP, LMHC Regional Director Central Florida Treatment Centers Addiction/ Substance Use Disorder Addiction is a Biopsychosocial Disease Has
More informationMethadone and Pregnancy
Methadone and Pregnancy Methadone/Buprenorphine 101 Workshop, April 1, 2017 Charissa Patricelli, MD, CCFP, ABAM Clinical Associate Professor, Dept. of Family Practice UBC American Board of Addiction Medicine
More informationManagement Options for Opioid Dependence:
Management Options for Opioid Dependence: Policy Implications and Recommendations Dan Ollendorf, PhD Sarah Jane Reed, MSc New England CEPAC Goal: To improve the application of evidence to guide practice
More informationCentral Appalachia: A Regional Response to an Opioid Epidemic in Pregnancy
Centers for Disease Control and Prevention Central Appalachia: A Regional Response to an Opioid Epidemic in Pregnancy Jenna Meyer MPH, RNC-MNN, IBCLC Public Health Advisor Therapies for Opioid Dependent
More informationBrief History of Methadone Maintenance Treatment
METHADONE Brief History of Methadone Maintenance Treatment Methadone maintenance treatment was on the cusp of the social revolution in the sixties. Doctors and public health workers had concluded what
More information2/28/2017. Substance Use Disorders + Pregnancy. Substance Use Disorders + Pregnancy. + Prevalence of the Problem
Substance Use Disorders Pregnancy Laura Lander, MSW, LICSW, Assistant Professor Department of Behavioral Medicine and Psychiatry, WVU Celebrating Connections Conference - April 2017 Substance Use Disorders
More informationEffective Strategies for Addressing the Needs of Substance Exposed Newborns & their Families Dixie L. Morgese, BA, CAP, ICADC.
Effective Strategies for Addressing the Needs of Substance Exposed Newborns & their Families Dixie L. Morgese, BA, CAP, ICADC Key Issues Significant increase in number of pregnant women addicted to prescription
More informationThe Importance of Psychological Treatment and Behavioral Support
The Importance of Psychological Treatment and Behavioral Support Michael W. Otto, PhD Department of Psychological and Brain Science Boston University Conflicts and Acknowledgements No industry funding
More informationChild Welfare and MOMS: Building Partnerships to Improve Care
Child Welfare and MOMS: Building Partnerships to Improve Care Goals Develop collaborative partnerships between MOMS pilot sites and child welfare agencies: Facilitate successful outcomes for clients Jointly
More information2/19/18. Today s talk. Today s talk. The Role of Behavioral Interventions in Buprenorphine Treatment of Opioid Use Disorders
The Role of Behavioral Interventions in Buprenorphine Treatment of Opioid Use Disorders Roger D. Weiss, MD Chief, Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, MA Professor of Psychiatry,
More informationRationale & Strategy For Integrating Buprenorphine Treatment Into Community Health Centers
Rationale & Strategy For Integrating Buprenorphine Treatment Into Community Health Centers Marwan S. Haddad, M.D. Community Health Center, Inc. Connecticut September 16, 2008 Community Health Center, Inc.
More informationBest Practice Workgroup Considerations. New Jersey Shared Values: Unified Child Welfare Practice Conference April 29, 2011
New Jersey Shared Values: Unified Child Welfare Practice Conference April 29, 2011 Evidence-based and Innovative Treatment Models: Setting the Stage for our Discussions Best Practice Workgroup Considerations
More informationOpioid use in pregnancy and Neonatal Abstinence Syndrome
Opioid use in pregnancy and Neonatal Abstinence Syndrome Morissa Ladinsky, MD Assoc. Professor of Pediatrics Division of General Pediatrics and Adolescent Medicine UAB Objectives 1. Understand the magnitude,
More informationBeyond Birth: A Comprehensive Recovery Center serving parenting women
Beyond Birth: A Comprehensive Recovery Center serving parenting women Session Objectives Highlight Plan of Safe Care Introduce the Beyond Birth Comprehensive Recovery Center Describe Levels of Care The
More informationCommunity-based interventions to reduce substance misuse among vulnerable and disadvantaged young people: Evidence and implications for public health
Date this evidence summary was written: April 2013 Community-based interventions to reduce substance misuse among vulnerable and disadvantaged young people: Evidence and implications for public health
More informationPITTSBURGH MERCY: COMPREHENSIVE INTEGRATED CARE JUNE 6, 2018
PITTSBURGH MERCY: COMPREHENSIVE INTEGRATED CARE JUNE 6, 2018 AN ENHANCED MEDICAL HOME MODEL FOR THE SMI POPULATION Comprehensive Care Patient Centered Care Coordinated Care Accessible Services Quality
More information8/24/2015 ADDICTION AND PREGNANCY. Fear ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY
ADDICTION AND PREGNANCY L y n é e B r o w n, M A, C D P & D o n n a L i v i n g s t o n, R N A D A P T E D F R O M J i m W a l s h, M D Objectives: Recognize common fears and myths associated with substance
More informationSafe Babies Foster Parent Training Program
Safe Babies Foster Parent Training Program Module 1: Introduction to the Safe Babies Program 1 Begin the process of group participation Learning outcomes Understand the purpose and origins of the Safe
More information201 KAR 9:270. Professional standards for prescribing or dispensing Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone.
201 KAR 9:270. Professional standards for prescribing or dispensing Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone. RELATES TO: KRS 311.530-311.620, 311.990 STATUTORY AUTHORITY: KRS
More informationOpioid Abuse Treatment in Pregnancy
University of Vermont ScholarWorks @ UVM Family Medicine Block Clerkship, Student Projects College of Medicine 2015 Opioid Abuse Treatment in Pregnancy Catherine A. Suppan Follow this and additional works
More informationScience = Solutions For Substance Use Disorders and Infant Outcomes. Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse
Science = Solutions For Substance Use Disorders and Infant Outcomes Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse Science = Solutions Increased Opioid Mortality: Greater
More informationNOWS The Time Caring for the Infant with Neonatal Opiate Withdrawal Syndrome
NOWS The Time Caring for the Infant with Neonatal Opiate Withdrawal Syndrome Meghan Howell, MD FAAP Assistant Professor of Pediatrics Clinical Director, Tulane NICU Graduate Clinic Tulane University School
More informationBehavioral Therapies for Methamphetamine Use
Behavioral Therapies for Methamphetamine Use Will M. Aklin, PhD National Institute on Drug Abuse Division of Therapeutics and Medical Consequences June 27, 2017 1 Behavioral Therapy Development Program
More informationJust Out of Reach: Women Who Use Drugs, Stigma and Barriers to Care Erin Bortel and Lyla Hunt AIDS Institute Office of Drug User Health
Just Out of Reach: Women Who Use Drugs, Stigma and Barriers to Care Erin Bortel and Lyla Hunt AIDS Institute Office of Drug User Health March 12, 2018 Envisioning a socially just system where all New Yorkers
More informationPERINATAL TOBACCO USE
PERINATAL TOBACCO USE Child Fatality Task Force Meeting December 7, 2015 Erin McClain, MA, MPH You Quit, Two Quit, UNC Center for Maternal & Infant Health Percentage Women & Tobacco Use in NC 2 50 45 40
More informationSUD Requirements. Proprietary
SUD Requirements Triage screening to determine eligibility and appropriateness (proper member placement) for admission and referral. A comprehensive bio-psychosocial evaluation must be completed prior
More informationThe role of behavioral interventions in buprenorphine treatment of opioid use disorders
The role of behavioral interventions in buprenorphine treatment of opioid use disorders Roger D. Weiss, MD Harvard Medical School, Boston, MA, McLean Hospital, Belmont, MA, USA Today s talk Review of studies
More informationOpioid Dependence During Pregnancy: Balancing Risk/Benefit
Opioid Dependence During Pregnancy: Balancing Risk/Benefit Peter R. Martin, M.D. Professor of Psychiatry and Pharmacology Vanderbilt University Acknowledgement: R01DA015713 Conflicts: None Outline I. Epidemiology
More informationREDUCING THE STIGMA OF OPIOID ADDICTION AMONG PERINATAL WOMEN. Lyn Raible, M.D., Ph.D. CMO, Aegis
REDUCING THE STIGMA OF OPIOID ADDICTION AMONG PERINATAL WOMEN Lyn Raible, M.D., Ph.D. CMO, Aegis ORGANIZATION The Opioid Crisis Breaking the Stigma Neurobiology of Opioid Addiction Treatment of Opioid
More informationAddressing Substance Use Among Pregnant Women and New Moms
ADRIANA KOHLER AND KATE MURPHY SENIOR POLICY ASSOCIATES AKOHLER@TXCHILDREN.ORG KMUPRHY@TXCHILDREN.ORG MARCH 20, 2018 Addressing Substance Use Among Pregnant Women and New Moms Opportunities to Improve
More informationSubstance Abuse Level of Care Criteria
Substance Abuse Level of Care Criteria Table of Contents SUBSTANCE ABUSE OUTPATIENT: Adolescent... 3 SUBSTANCE ABUSE PREVENTION: Adult... 7 OPIOID MAINTENANCE THERAPY: Adult... 8 SUBSTANCE ABUSE INTERVENTION:
More informationIMPACT OF INCLUSION/ EXCLUSION CRITERIA ON ENROLLMENT
2014 CTN Web Seminar Series IMPACT OF INCLUSION/ EXCLUSION CRITERIA ON ENROLLMENT Presented by: Robert Lindblad, MD & Gaurav Sharma, PhD NIDA Clinical Coordinating & Data and Statistics Centers The EMMES
More informationMaternal and Child Health, Substance Abuse Ohio Department of Health, Bureau of Maternal Child and Family Health
Maternal and Child Health, Substance Abuse Ohio Department of Health, Bureau of Maternal Child and Family Health Columbus, Ohio Assignment Description The rapid advance of the opiate crisis has had far
More informationHealth Systems and Addiction: Provider Issues
Health Systems and Addiction: Provider Issues The Emerging Roles of Primary Care Patrick G. O Connor MD, MPH Dan and Amanda Adams Professor of General Medicine Chief, General Internal Medicine Yale University
More informationADDING EVEN MORE SUBSTANCE TO MANAGED CARE
HEALTH WEALTH CAREER ADDING EVEN MORE SUBSTANCE TO MANAGED CARE OPTIMIZING MEDICAID TO RESPOND TO SUBSTANCE USE DISORDERS NATIONAL ACADEMY FOR STATE HEALTH POLICY 30TH ANNUAL STATE HEALTH POLICY CONFERENCE
More informationGUIDELINES FOR POST PEDIATRICS PORTAL PROGRAM
GUIDELINES FOR POST PEDIATRICS PORTAL PROGRAM Psychiatry is a medical specialty that is focused on the prevention, diagnosis, and treatment of mental, addictive, and emotional disorders throughout the
More informationEffects of Prenatal Illicit Drug. Use on Infant and Child
Effects of Prenatal Illicit Drug Use on Infant and Child Development Andrew Hsi, MD, MPH Larry Leeman, MD, MPH Family Medicine MCH Grand Rounds 6 July 2011 Objectives for Presentation At the end of this
More informationProject Connections Buprenorphine Program
Project Connections Buprenorphine Program Program & Client Summary 2010-2017 Behavioral Health Leadership Institute November 2017 November 2017 1 Table of Contents I. Overview of the Project Connections
More informationNeonatal Abstinence Syndrome (NAS)
Neonatal Abstinence Syndrome (NAS) Jodi Jackson, MD Neonatologist Children's Mercy Hospital Associate Professor of Pediatrics University of Missouri-Kansas City School of Medicine Medical director NICU
More informationTESTIMONY Of Pam Gehlmann Executive Director/ Assistant Regional Director Pinnacle Treatment Centers Alliance Medical Services-Johnstown
TESTIMONY Of Pam Gehlmann Executive Director/ Assistant Regional Director Pinnacle Treatment Centers Alliance Medical Services-Johnstown Center for Rural Pennsylvania On Confronting the Heroin Epidemic
More informationROSC & MAT II: Opioid Treatment Services
ROSC & MAT II: Opioid Treatment Services September 23, 2015 Stan DeKemper Executive Director Indiana Credentialing Association on Addiction and Drug Abuse 1 GOALS Review medication assisted recovery Identify
More informationWhat is Treatment Planning? Clinical Evaluation: Treatment Planning Goals and Objectives
Clinical Evaluation: Treatment Planning Goals and Objectives 1) Define Treatment Planning 2) Understanding of Correlation Between Assessment and Treatment Planning 3) Overview of Treatment Planning Process
More informationManaging drug misuse in pregnancy and beyond
Managing drug misuse in pregnancy and beyond Dr Emily Finch Clinical Director Addictions CAG, South London and Maudsley Foundation NHS Trust Rachel Evans, Adfam 1 / Aims of the session Update on management
More informationMAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids
MAT IN PREGNANCY R. COREY WALLER MD, MS PRINCIPAL, HEALTH MANAGEMENT ASSOCIATES FACULTY, INSTITUTE FOR HEALTHCARE INNOVATION (IHI) CHAIR, LEGISLATIVE ADVOCACY COMMITTEE, ASAM KAYLA LIFE STAGE 1: ADOLESCENCE
More informationPREGNANCY SMOKING AND CHILD OUTCOMES FROM BIRTH TO 15 MONTHS: FINDINGS FROM NORTHEAST TENNESSEE. Beth Bailey, PhD
PREGNANCY SMOKING AND CHILD OUTCOMES FROM BIRTH TO 15 MONTHS: FINDINGS FROM NORTHEAST TENNESSEE Beth Bailey, PhD Associate Professor of Family Medicine, East Tennessee State University Associate Director
More information9/19/13. Postpartum Counseling for Women in MAT. Katie Clark MSPH, CSAC. A little about Katie. Definitions. MAT: Medication-Assisted Treatment
Postpartum Counseling for Women in MAT Katie Clark MSPH, CSAC A little about Katie SUD and PH crossroads BA Health Arts and Sciences Goddard College MSPH MCH UNC Project Lazarus, Yale, CHER Solutions LLC
More informationMaternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015
Maternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015 Objectives Discuss the current scope of maternal substance use and abuse List examples
More informationMedication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment
Medication Assisted Treatment MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment Opioid Drugs Opium Morphine Heroin Codeine Oxycodone Roxycodone Oxycontin
More informationTreating Women for Substance Use Disorders and Their Children: Evidence-based Care
Treating Women for Substance Use Disorders and Their Children: Evidence-based Care Hendrée E. Jones, PhD Executive Director, UNC Horizons Professor, Department of Obstetrics and Gynecology School of Medicine,
More informationSubstance Abuse Suboxone Treatment
Substance Abuse Suboxone Treatment Program Waterbury Hospital Infectious Disease Clinic Richard Smith, LCSW Leonard Savage, Consumer Steven I. Aronin, MD FACP, Program Director Ryan White All Grantee Meeting
More informationAppendix F Federation of State Medical Boards
Appendix F Federation of State Medical Boards Model Policy Guidelines for Opioid Addiction Treatment in the Medical Office SECTION I: PREAMBLE The (name of board) recognizes that the prevalence of addiction
More informationTobacco Cessation for Women of Reproductive Age. Erin McClain, MA, MPH
Tobacco Cessation for Women of Reproductive Age Erin McClain, MA, MPH Tobacco Use During Pregnancy in NC 2 1 in 10 babies in NC are born to women reporting tobacco use during pregnancy In some counties
More informationGoToWebinar Housekeeping: Attendee participation
GoToWebinar Housekeeping: Attendee participation Your Participation Join audio: Choose Mic & Speakers to use your computer for audio. Not recommended for desktop units but works with laptops If not using
More informationReferral to the Women s Alcohol and Drug Service (WADS) Procedure
1. Purpose The following document describes criteria for the referral to Women s Alcohol and Drug Service (WADS) and how a referral is taken and processed. This includes the referral for clinical care
More informationModels of good practice in drug treatment in Europe. Project group
Models of good practice in drug treatment in Europe ( moretreat 2006329 ) Project group Hamburg, London, Rome, Stockholm, Vienna, Warsaw, Zurich Project duration: 17 months from April 2006 August 2008
More information1/26/2018 PREVENTING THE RETRAUMITIZATION OF CHILDREN FROM ADDICTED FAMILIES THE PROBLEM RISK FACTORS FOR ENDANGERMENT
PREVENTING THE RETRAUMITIZATION OF CHILDREN FROM ADDICTED FAMILIES Susan Kilman LCSW, AADC THE PROBLEM ABOUT 1 IN 8 (8.7 MILLION) AGED 17 OR YOUNGER LIVE IN HOUSEHOLDS WITH AT LEAST ONE PARENT WHO HAD
More informationEnhanced Substance Abuse Management in Higher Risk Populations
Enhanced Substance Abuse Management in Higher Risk Populations Pano Yeracaris, MD, MPH Vice President & Chief Medical Officer, Network Health Annual Community Health Institute May 9-11, 2012 Resort & Conference
More informationKurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center
Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Data from the National Vital Statistics System Mortality The age-adjusted rate of drug overdose deaths in the United States
More informationRECOMMENDATIONS FOR HEALTH CARE PROVIDERS
Ending Addiction Changes Everything RECOMMENDATIONS FOR HEALTH CARE PROVIDERS CRITICAL ADDICTION PREVENTION, TREATMENT AND MANAGEMENT SERVICES TO INCLUDE IN ROUTINE HEALTH CARE PRACTICE JULY 2013 In the
More informationMarijuana During Pregnancy: An Overview
Marijuana During Pregnancy: An Overview Marijuana: Epidemiology Marijuana is the most commonly used illicit drug and, after alcohol and tobacco, the most commonly used drug during pregnancy (1) 48-60%
More informationAddictions 101: Understanding, Recognizing, and Treating the Disease State!
Addictions 101: Understanding, Recognizing, and Treating the Disease State! www.overdosefreepa.org Criminal Justice Personnel Curricula Core Component 1 2014, Overdose Prevention Coalition! The OverdoseFreePA
More informationNeonatal Abstinence Syndrome Questions & Answers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012)
Neonatal bstinence Syndrome Questions & nswers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012) For more information and to download a copy of the NS Clinical Practice Guidelines, please visit
More informationHaymarket Center. Haymarket Center is the Chicago area s largest and most comprehensive provider of substance use and mental health treatment.
EXPERT, COMPREHENSIVE SOLUTIONS IN AN ERA OF CRISIS: HOPE STARTS HERE HAYMARKET CENTER ANNUAL REPORT 2017 is the Chicago area s largest and most comprehensive provider of substance use and mental health
More informationClinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)
Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT) What has changed? Effective January 16, 2018, Coordinated Care will change the requirement for form HCA 13-333 Medication
More informationContents Opioid Treatment Program Core Program Standards... 2
2017 OPIOID TREATMENT PROGRAM PROGRAM DESCRIPTIONS Contents Opioid Treatment Program Core Program Standards... 2 Court Treatment (CT)... 2 Detoxification... 2 Day Treatment... 3 Health Home (HH)... 3 Integrated
More informationProviding Medication Assisted Treatment for Opioid Use Disorder in Family Medicine Clinics in Vermont
University of Vermont ScholarWorks @ UVM Family Medicine Block Clerkship, Student Projects College of Medicine 2016 Providing Medication Assisted Treatment for Opioid Use Disorder in Family Medicine Clinics
More informationLearning Objectives. Serving Pregnant Women Affected by Substance Use Disorders in Healing to Wellness Court: Sharing Lessons
Serving Pregnant Women Affected by Substance Use Disorders in Healing to Wellness Court: Sharing Lessons Marianna Corona Jennifer Foley September 12, 2017 Learning Objectives 2017 Improving Family Outcomes
More informationState Targeted Opioid Response Initiative (STORI) Fee-for-Service (FFS) Open Enrollment
State Targeted Opioid Response Initiative (STORI) Fee-for-Service (FFS) Open Enrollment DEPARTMENT OF HUMAN SERVICES (DHS) DIVISION OF MENTAL HEALTH & ADDICTION SERVICES (DMHAS) STORI INFORMATIONAL WEBINAR
More informationOUTPATIENT & RESIDENTIAL
Substance Abuse OUTPATIENT & RESIDENTIAL SUBSTANCE ABUSE FACILITIES FOR PREGNANT & PARENTING WOMEN A Resource Guide for Providers Residential and Outpatient Substance Abuse Treatment Facilities in Philadelphia
More informationInformation for Professionals
LEAP saved three lives when my son went into treatment; they saved my son s life who had already been on the edge of death twice due to substance overdoses. They also saved my wife s life, and my own.
More informationTREATING OPIOID ADDICTION IN HOMELESS POPULATIONS
TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS Challenges and Opportunities Providing Medication Assisted Treatment (Buprenorphine) August 18, 2016 SPEAKERS TODAY Nilesh Kalyanaraman, MD, Chief Health
More informationReferral to the Women s Alcohol and Drug Service (WADS) Procedure
Procedure Referral to the Women s Alcohol and Drug Service (WADS) Procedure. Purpose The following document describes criteria for the referral to Women s Alcohol and Drug Service (WADS) and how a referral
More informationPERINATAL TOBACCO USE
PERINATAL TOBACCO USE Child Fatality Task Force Perinatal Health Committee Meeting November 4, 2015 Erin McClain, MA, MPH You Quit, Two Quit, UNC Center for Maternal & Infant Health Percentage Women &
More informationINTRODUCTION. Baltimore, Maryland 6 School of Medicine West Virginia University, Morgantown, West Virginia
The American Journal on Addictions, 27: 92 96, 2018 Copyright 2018 American Academy of Addiction Psychiatry ISSN: 1055-0496 print / 1521-0391 online DOI: 10.1111/ajad.12687 Brief Report: Treating Women
More informationHHS Priorities and Actions to Support Treatment for Those with Opioid Use Disorder
HHS Priorities and Actions to Support Treatment for Those with Opioid Use Disorder Brett Giroir, U.S. Department of Health and Human Services Join the conversation at #OUDTreatment #EndTheStigma Expanding
More informationAlcohol and Other Drug Service Definitions
Table of Contents OAC 3793:2-1-08 Treatment services (E) Consultation... 2 (F) Referral and information service... 2 (G) Intervention service... 2 (H) Hotline service... 2 (I) Training service (non-prevention)...
More informationThe Opioid Crisis: What Can Physicians Do About It?
The Opioid Crisis: What Can Physicians Do About It? Richard S. Schottenfeld, M.D. Professor and Chair, Department of Psychiatry and Behavioral Sciences 2018 Louis J. Kolodner Memorial Lecture Disclosures
More informationNEONATAL ABSTINENCE SYNDROME (NAS) AKA NEWBORN DRUG WITHDRAWAL:THE NEWARK EXPERIENCE
NEONATAL ABSTINENCE SYNDROME (NAS) AKA NEWBORN DRUG WITHDRAWAL:THE NEWARK EXPERIENCE Salma Ali MD, Debra Brendel RN, BSN, MSN and Ona Fofah MD Division of Neonatology and Newborn Medicine Department of
More informationMARIJUANA USE AMONG PREGNANT AND POSTPARTUM WOMEN
MARIJUANA USE AMONG PREGNANT AND POSTPARTUM WOMEN Symposium on Marijuana Research in Washington May 18, 2018 THERESE GRANT, PH.D. PROFESSOR, DEPARTMENT OF PSYCHIATRY & BEHAVIORAL SCIENCES UNIVERSITY OF
More informationKRISANNA DEPPEN, MD FAMILY MEDICINE, ADDICTION MEDICINE GRANT MEDICAL CENTER-OHIOHEALTH COLUMBUS, OH
KRISANNA DEPPEN, MD FAMILY MEDICINE, ADDICTION MEDICINE GRANT MEDICAL CENTER-OHIOHEALTH COLUMBUS, OH IF THESE MOMS REALLY CARED ABOUT THEIR BABIES, THEY WOULD JUST QUIT Those who can quit, often do Addiction
More informationCorporate Medical Policy
Corporate Medical Policy Buprenorphine Implant for Treatment of Opioid Dependence File Name: Origination: Last CAP Review: Next CAP Review: Last Review: buprenorphine_implant_for_treatment_of_opioid_dependence
More informationPriority Alignment. Birth Outcomes. Goal 1-Reduce preterm births. Goal 2 - Reduce substance misuse in pregnant women
Alignment Birth Outcomes Goal 1-Reduce preterm births Birth Outcomes Infant Mortality - Empower People - Reproductive and Sexual Health - Reduce preterm births - Reduce the fetal and infant deaths - Reduce
More informationSupplementary Materials: The Effects of Alcohol and Drugs of Abuse on Maternal Nutritional Profile During Pregnancy
S1 of SX Supplementary Materials: The Effects of Alcohol and Drugs of Abuse on Maternal Nutritional Profile During Pregnancy Giorgia Sebastiani 1, *, Cristina Borrás Novell 1, Miguel Alsina Casanova 1,
More informationVivitrol Drug Court and Medication Assisted Treatment
Vivitrol Drug Court and Medication Assisted Treatment Amy Black, CNP and Judge Fred Moses Court program Self-starters Mission Statement To provide court-managed, medically assisted drug intervention treatment
More informationContinuing Care Strategies for Long Term Recovery
Continuing Care Strategies for Long Term Recovery Richard Spence, PhD, ACSW Addiction Technology Transfer Center School of Social Work University of Texas at Austin Three Concepts That will Change the
More informationCaron Renaissance. Caron Renaissance
Located in Boca Raton, Florida, offers a unique longer-term continuum of care offering unparalleled behavioral healthcare and clinical services for young adults and adults. Keys to Success Innovator in
More information